14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
THRM vs DORM: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Dorman Products, Inc. New (DORM) is the stronger overall head-to-head candidate over Gentherm Inc (THRM) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, R&D & Supply-Chain Moat). THRM carries a Unified Composite Score of 35.4/100 (SELL) at $28.53 (9.4x Forward P/E, 7.1% operating margin), whereas DORM carries 36.0/100 (SELL) at $131.87 (14.6x Forward P/E, 15.6% operating margin).
Defensive Composite Rating Caution: Although DORM compares more favorably head-to-head, both THRM (35.4/100 SELL) and DORM (36.0/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
Technical & Structure Timing Caution: THRM is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 40.6); meanwhile DORM trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 50.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Competes within the Auto Parts value chain with $3.9B market capitalization and 15.6% operating margin.
OpEx & R&D Reinvestment25.5% of Rev ($554M)
90D Engineering Disclosures0 Published
Investor FAQ THRM vs DORM Key Questions & Quantitative Answers
As of Nov 16, 2026, Dorman Products, Inc. New (DORM) is the stronger overall head-to-head candidate over Gentherm Inc (THRM) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, R&D & Supply-Chain Moat). THRM carries a Unified Composite Score of 35.4/100 (SELL) at $28.53 (9.4x Forward P/E, 7.1% operating margin), whereas DORM carries 36.0/100 (SELL) at $131.87 (14.6x Forward P/E, 15.6% operating margin). Defensive Composite Rating Caution: Although DORM compares more favorably head-to-head, both THRM (35.4/100 SELL) and DORM (36.0/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: THRM is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 40.6); meanwhile DORM trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 50.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
THRM leads the Growth & Scale pillar: THRM posts +4.7% YoY revenue growth and +798.1% YoY earnings growth on $2.68B TTM revenue (23.7% gross margin, 7.1% operating margin), compared with DORM at +3.3% YoY revenue growth and -20.2% YoY earnings growth on $2.17B TTM revenue (41.1% gross margin, 15.6% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), THRM cumulative revenue shifted +42.9% while DORM shifted +119.6%. In operating R&D and SG&A reinvestment, THRM deploys 16.6% of Rev ($444M) (0 90-day corporate R&D disclosures) versus 25.5% of Rev ($554M) (0 disclosures) for DORM.
THRM screens cheaper on headline valuation multiples. THRM trades at 9.4x Forward P/E, 103.9x Trailing P/E, 1.02x PEG, and 0.7x EV/Revenue (1.2% FCF margin), whereas DORM trades at 14.6x Forward P/E, 19.7x Trailing P/E, 1.17x PEG, and 2.0x EV/Revenue (12.4% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against THRM (1.3% ROE) versus DORM (13.3% ROE) capital efficiency.
In options market volatility and institutional positioning, THRM carries 60.2% implied volatility (3rd %ile, Compressed (<25th %ile)), a 0.10x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (0.99β · 72% Vol realized risk). By comparison, DORM carries 37.8% implied volatility (26th %ile, Balanced (25th–60th %ile)), a 1.00x (Balanced) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.70β · 34% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.